{"id":493986,"date":"2021-08-12T10:24:30","date_gmt":"2021-08-12T08:24:30","guid":{"rendered":"https:\/\/www.albinfo.ch\/?p=493986"},"modified":"2021-08-12T10:24:30","modified_gmt":"2021-08-12T08:24:30","slug":"swissmedic-approuve-lextension-de-lindication-du-vaccin-spikevax-aux-personnes-de-12-a-17-ans","status":"publish","type":"post","link":"https:\/\/www.albinfo.at\/fr\/swissmedic-approuve-lextension-de-lindication-du-vaccin-spikevax-aux-personnes-de-12-a-17-ans\/","title":{"rendered":"Swissmedic approuve l\u2019extension de l\u2019indication du vaccin Spikevax aux personnes de 12 \u00e0 17 ans"},"content":{"rendered":"<div class=\"contentHead\"><\/div>\n<div class=\"mod mod-nsbnewsdetails\">\n<p><strong>Swissmedic a soigneusement \u00e9valu\u00e9 la demande d\u2019extension d\u2019indication d\u00e9pos\u00e9e par Moderna Switzerland S.\u00e0.r.l. et a \u00e9tendu l\u2019autorisation \u00e0 dur\u00e9e limit\u00e9e du vaccin contre le COVID-19 Spikevax de Moderna pour la pr\u00e9vention de la maladie \u00e0 coronavirus aux adolescents \u00e2g\u00e9s de 12 \u00e0 17 ans.<\/strong><\/p>\n<p>Swissmedic a examin\u00e9 la demande d\u2019extension d\u2019indication d\u00e9pos\u00e9e le 11\u00a0juin\u00a02021 \u00e0 un rythme acc\u00e9l\u00e9r\u00e9, dans le cadre d\u2019une proc\u00e9dure de soumission en continu. Les r\u00e9sultats d\u2019une \u00e9tude en cours men\u00e9e chez 3732\u00a0enfants \u00e2g\u00e9s de 12 \u00e0 17\u00a0ans ont \u00e9t\u00e9 fournis et examin\u00e9s.<\/p>\n<p>Dans le groupe d\u2019\u00e2ge \u00e9tudi\u00e9 et \u00e0 la m\u00eame posologie que chez l\u2019adulte, le vaccin de cette \u00e9tude clinique a montr\u00e9 une r\u00e9action immunitaire comparable (mesur\u00e9e \u00e0 l\u2019aune du taux d\u2019anticorps contre le SARS-CoV-2) \u00e0 celle obtenue chez les jeunes adultes \u00e2g\u00e9s de 18 \u00e0 25\u00a0ans. Les effets secondaires les plus fr\u00e9quents chez les enfants \u00e2g\u00e9s de 12 \u00e0 17\u00a0ans sont \u00e9galement semblables \u00e0 ceux des personnes de 18\u00a0ans et plus. L\u2019\u00e9tude clinique du vaccin a montr\u00e9 que chez les adolescents, l\u2019efficacit\u00e9 contre la maladie symptomatique (au moins un sympt\u00f4me et un test PCR positif) \u00e9valu\u00e9e \u00e0 partir de 14 jours apr\u00e8s la deuxi\u00e8me dose \u00e9tait de 93%. Les effets ind\u00e9sirables ont g\u00e9n\u00e9ralement dur\u00e9 un \u00e0 trois jours et peuvent \u00eatre plus marqu\u00e9s apr\u00e8s la deuxi\u00e8me dose.<\/p>\n<p>Le vaccin doit\u00a0\u2013 tout comme chez les personnes de plus de 18\u00a0ans\u00a0\u2013 \u00eatre administr\u00e9 deux fois, \u00e0 quatre semaines d\u2019intervalle.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>L\u2019\u00e9tude clinique du vaccin a montr\u00e9 que chez les adolescents, l\u2019efficacit\u00e9 contre la maladie symptomatique (au moins un sympt\u00f4me et un test PCR positif) \u00e9valu\u00e9e \u00e0 partir de 14 jours apr\u00e8s la deuxi\u00e8me dose \u00e9tait de 93%<\/p>\n","protected":false},"author":4,"featured_media":457280,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18826,22521,1170],"tags":[],"vendi":[],"content_country":[31835,31838,31840],"class_list":["post-493986","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lajme-jeta-ne-zvicer-fr","category-coronavirus-minutes-par-minutes","category-vivre-en-suisse","content_country-austria-fr","content_country-germany-fr","content_country-zvicer-fr"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.albinfo.at\/fr\/wp-json\/wp\/v2\/posts\/493986","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.albinfo.at\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.albinfo.at\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.albinfo.at\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.albinfo.at\/fr\/wp-json\/wp\/v2\/comments?post=493986"}],"version-history":[{"count":0,"href":"https:\/\/www.albinfo.at\/fr\/wp-json\/wp\/v2\/posts\/493986\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.albinfo.at\/fr\/wp-json\/wp\/v2\/media\/457280"}],"wp:attachment":[{"href":"https:\/\/www.albinfo.at\/fr\/wp-json\/wp\/v2\/media?parent=493986"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.albinfo.at\/fr\/wp-json\/wp\/v2\/categories?post=493986"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.albinfo.at\/fr\/wp-json\/wp\/v2\/tags?post=493986"},{"taxonomy":"vendi","embeddable":true,"href":"https:\/\/www.albinfo.at\/fr\/wp-json\/wp\/v2\/vendi?post=493986"},{"taxonomy":"content_country","embeddable":true,"href":"https:\/\/www.albinfo.at\/fr\/wp-json\/wp\/v2\/content_country?post=493986"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}